Company Quick10K Filing
IntelliSense Solutions
10-Q 2020-06-30 Filed 2020-08-12
10-Q 2020-03-31 Filed 2020-06-22
S-1 2020-03-30 Public Filing
10-K 2019-12-31 Filed 2020-03-16
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-K 2019-03-31 Filed 2019-07-09
10-Q 2018-12-31 Filed 2019-02-19
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-13
10-K 2018-03-31 Filed 2018-07-05
10-Q 2017-12-31 Filed 2018-02-08
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-11
10-K 2017-03-31 Filed 2017-06-29
10-Q 2016-12-31 Filed 2017-02-10
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-K 2016-03-31 Filed 2016-06-29
10-Q 2015-12-31 Filed 2016-02-16
10-Q 2015-09-30 Filed 2015-11-02
10-Q 2015-06-30 Filed 2015-08-10
10-K 2015-03-31 Filed 2015-06-10
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-K 2014-03-31 Filed 2014-06-30
10-Q 2013-12-31 Filed 2014-02-13
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-09-13
8-K 2020-06-24
8-K 2020-05-27
8-K 2020-05-19
8-K 2020-05-07
8-K 2020-04-28
8-K 2020-03-05
8-K 2020-02-09
8-K 2020-01-29
8-K 2020-01-02
8-K 2019-12-31
8-K 2019-11-01
8-K 2019-09-17
8-K 2019-03-29
8-K 2019-03-21
8-K 2019-01-08
8-K 2018-11-02
8-K 2018-05-16

IntelliSense Solutions Financials

INLL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Rebel Group (REBL) 0% 0.0 -1,380% 703,462,000 4,932,953,000 139,834,000 0 -9,707,897,000 -9,659,520,000 -395,458,000
Generex Biotechnology (GNBT) 21% 0.0 -49% 52,240,249,000 43,296,964,000 1,764,009,000 374,238,000 -25,717,337,000 -18,297,230,000 -540,256,000
Poverty Dignified (POVD) 0.0 -4,053% 49,338,000 3,079,595,000 0 0 -1,999,816,000 -1,786,224,000 -40,929,000
Zhong Ya (WLUC) 0.0 0 62,889,000 0 0 -561,596,000 -561,596,000 -2,000
Weyland Tech (WEYL) 18% 2.2 -24% 11,699,111,000 2,217,605,000 24,630,065,000 4,371,806,000 -2,778,623,000 -2,702,174,000 -5,820,631,000
Longbau (LNGB) 4% -1.0 2% 10,659,548,000 10,135,830,000 4,882,008,000 209,757,000 164,602,000 221,914,000 -232,744,000
Scandium International Mining (SCY) 0.1 -171% 956,938,000 303,212,000 0 0 -1,636,126,000 -1,634,396,000 -219,146,000
Aprea Therapeutics (APRE) 8.4 -11% 57,336,058,000 9,942,725,000 0 0 -6,249,419,000 -6,249,419,000 -52,334,104,000
IntelliSense Solutions (INLL) 0.0 -7,286% 2,442,000 272,894,000 0 0 -177,936,000 -163,709,000 -2,444,000
Metropolitan Life Insurance (MLIC) 0% -1.8 1% 437,745,000,000,000 403,121,000,000,000 37,348,000,000,000 0 4,559,000,000,000 4,960,000,000,000 -8,986,000,001,000
Zeta Acquisition I (ZETAI) 0.2 -649% 4,412,000 323,686,000 0 0 -28,634,000 -17,937,000 -4,414,000
Ando Holdings (ANDO) 1.1 -74% 73,214,000 159,843,000 0 0 -54,299,000 -53,972,000 -60,816,000
Po Yuen Cultural (POYE) 0.0 -1,973% 1,000,000 68,122,000 0 0 -19,731,000 -19,731,000 -2,000
Advanced Biomedical Technologies (ABMT) 0.0 -321% 218,459,000 6,588,633,000 0 0 -701,078,000 -701,078,000 -10,879,000
Kyto Technology & Life Science (KBPH) 0% 0.8 -12% 2,577,822,000 65,986,000 14,700,000 0 -314,665,000 -314,640,000 -238,429,000
Federal Home Loan Bank of Topeka (FHLBT) 29.6 0% 57,131,130,000,000 54,472,808,000,000 0 0 132,964,000,000 1,095,234,000,000 32,380,960,999,000
CNL Healthcare Properties II (CHPII) 67% -4.4 68,889,100% 8,276,504,000 5,549,239,000 -688,891,000 1,137,086,000 -4,981,415,000
Original Source Music (OSMU) 0.0 743,400% 35,313,000 0 0 -7,434,000 -7,434,000 -2,000
Graham Alternative Investment Fund I (GAIF) -0.0 0% 29,076,020,000 1,126,459,000 0 0 0 4,713,000 -2,000
JiaLiJia Group (RZZN) 0.0 -1,721% 4,000,000 139,328,000 0 0 -68,826,000 -68,826,000 -2,000

Balance Sheet ($)2013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash10,416,00022,979,00054,146,00036,501,00031,150,00027,950,00024,364,00011,863,0006,072,0002,497,000234,0008,124,0003,269,0008,106,0003,493,0002,660,0003,718,0006,559,0002,712,00010,153,00050,236,0001,360,00034,342,00026,322,0008,979,0002,442,000
Accounts Receivable
Inventory
PP&E
Assets10,416,00022,979,00054,146,00037,517,00032,635,00028,301,00024,381,00011,863,0006,577,0002,497,000234,0008,124,00028,269,0008,106,0003,493,0002,660,0003,718,0006,559,0002,712,00010,153,00050,236,0004,277,00037,259,00026,322,0008,979,0002,442,000
Accounts Payable
Long-Term Debt
Liabilities2,162,0004,999,0004,851,0006,051,0008,569,0008,836,0009,726,0005,701,00010,087,00031,576,00040,731,00066,272,00048,694,00037,259,00038,770,00046,990,00056,338,00064,991,00065,453,00082,458,000132,225,000101,014,000150,457,000198,167,000222,708,000272,894,000
Stockholders' Equity8,254,00017,980,00049,295,00031,466,00024,066,00019,465,00014,655,0006,162,000-3,510,000-29,079,000-40,497,000-58,148,000-20,425,000-29,153,000-35,277,000-44,330,000-52,620,000-58,432,000-62,741,000-72,305,000-81,989,000-96,737,000-113,198,000-171,845,000-213,729,000-270,452,000
Income Statement ($)2013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A962,0001,376,0001,893,00013,660,0001,200,0002,651,0001,035,0002,668,0001,228,0001,186,0002,894,000-14,0001,070,000816,000818,0001,629,000982,000878,000867,000938,000296,0001,974,000-1,076,000543,0008,621,0003,750,000
Tax000000003,321,000-3,321,0009,013,000
Net Income-9,726,000-7,576,000-4,551,000-17,829,000-7,400,000-4,601,000-4,810,000-8,869,000-9,672,000-25,569,000-11,418,000-17,651,00037,723,000-8,728,000-6,123,000-9,053,000-8,290,000-5,812,000-4,309,000-9,564,000-9,684,000-14,748,000-16,461,000-58,647,000-46,105,000-56,723,000
Cash Flow ($)2013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-9,564,000-6,637,000-2,801,000-17,645,000-5,351,000-3,200,000-3,586,000-12,501,000-5,791,000-3,575,000-2,263,000-12,110,000-4,855,0004,837,000-4,613,000-833,000-8,942,000-8,159,000-3,847,000-2,559,000-9,917,000-22,876,000-53,020,000-32,343,000-46,537,000
Cash Investing
Cash Financing19,980,000-780,00033,968,00000010,000,00011,000,000010,000,00050,000,000-26,000,00045,000,00015,000,00040,000,000